4 November 2024
Who does this notice affect?
Importers and brokers of commodities lodged in tariffs:
- 3002.12 - Antisera and other blood fractions
- 3002.15 - Immunological products, put up in measured doses or in forms or packings for retail sale.
- 3822.19 - Other diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits, other than those of 3006; Certified reference materials.
What has changed?
Starting 11 November 2024, new community protection profile questions will be implemented for tariffs 3002.12, 3002.15 and 3822.19 in the Integrated Cargo System (ICS).
The profile questions will undergo a trial period of 4 weeks, during which they will be reviewed for accuracy and effectiveness.
There are no changes to the import conditions for commodities lodged under tariffs 3002.12, 3002.15 or 3822.19. Importers and brokers must understand and comply with the current import conditions as outlined in BICON.
Why is this changing?
The profile questions for tariffs 3002.12, 3002.15 and 3822.19 are designed to easily identify specific commodity import pathways within the tariffs, supporting timely and accurate biosecurity processing while enhancing our monitoring capabilities.
What do I need to do?
Customs brokers lodging declarations in ICS on or after 11 November 2024 under tariffs 3002.12, 3002.15 and 3822.19 will need to answer the related CP questions as follows.
Customs brokers must answer ‘Y’ to these questions if the goods are to be imported via the BICON commodity import pathways outlined below. If the goods are not imported by the commodity import pathway, then customs brokers must answer ‘N’. It is possible that all answers will be ‘N’.
| Tariff code | Profile question | YES response for BICON commodity import pathway |
|---|---|---|
| 3822.19 | Biosecurity: Are the goods test kits that are not testing for disease agents, and accompanied with a valid import permit? This includes haematology tests; hormone tests including pregnancy tests; drug tests; chemical tests; genetic tests; environmental test kits including soil test kits; and allergy test kits for use on humans only. | Test kits — Test kits not testing for disease agents |
| 3002.12 3002.15 | Biosecurity: Are the goods imported human fluids and tissues and for human therapeutic use only? This may include human organs, human blood or blood components, human nucleic acids, human fluids, human proteins, enzymes, human secretions, excretions or exudates (excluding milk), human semen, embryos or ova, human tissue extracts, or human tissue. | Human therapeutics — Therapeutic use — Human derived materials (excluding antibodies, cell lines and human milk) |
| Biosecurity: Are the goods human therapeutics and medicines for use in clinical trials (including accountability and disposal), and accompanied with a valid import permit? | Human therapeutics — Therapeutic use — Human therapeutics and medicines for use in clinical trials (including accountability and disposal) | |
| Biosecurity: Are the goods fully finished human therapeutics and medicines with a TGA AUST R number, and accompanied by a valid import permit? | Human therapeutics — Therapeutic use — TGA AUST R human therapeutics and medicines | |
| Biosecurity: Are the goods purified antibodies raised against inorganic material or antigens from multicellular organisms, and accompanied by a valid import permit? | Purified antibodies – Raised against inorganic material or antigens from multicellular organisms |
Further information
If you require further information, please email the CBIS program on CBIS@aff.gov.au. Alternatively, please contact Imports on 1800 900 090 or imports@aff.gov.au.
Biosecurity import conditions are available on the department’s Biosecurity Import Conditions database (BICON).